论文部分内容阅读
1994年6月～1997年6月对59例恶性胸水的患者施行顺铂胸腔注射时,并静脉点滴复方丹参注射液治疗,经临床观察效果较好,现报道如下: 临床资料 59例恶性胸水患者被分为两组,其中治疗组32例,男21例,女11例;年龄39～72岁,平均56.4岁。病理诊断为肺腺癌9例,肺鳞癌15例,肺小细胞癌3例,乳腺癌1例,卵巢癌2例;原因不明者2例;对照组27例,男19例,女8例,年龄42～70岁,平均59.1岁,病理诊断为肺腺癌9例,肺鳞癌16例,肺小细胞癌2例。所有患者均有不同程度的咳嗽、呼吸困难、胸部X线或CT检查可见胸腔
From June 1994 to June 1997, 59 patients with malignant pleural effusion were treated with cisplatin intrapleural injection and intravenous drip compound Danshen injection. The clinical observation showed good results. The following are reported: Clinical data 59 patients with malignant pleural effusion Divided into two groups, including the treatment group of 32 patients, 21 males and 11 females; aged 39 to 72 years, mean 56.4 years old. The pathological diagnosis included 9 cases of lung adenocarcinoma, 15 cases of lung squamous cell carcinoma, 3 cases of small cell lung cancer, 1 case of breast cancer, 2 cases of ovarian cancer, 2 cases of unexplained disease, 27 cases of control group, 19 cases of male and 8 cases of female The age ranged from 42 to 70 years old with an average age of 59.1 years. Pathological diagnosis included 9 cases of lung adenocarcinoma, 16 cases of lung squamous cell carcinoma, and 2 cases of small cell lung cancer. All patients had different degrees of cough, dyspnea, chest X-ray or CT examination visible chest cavity